Vaxinano Revenue and Competitors
Employee Data
- Vaxinano has 14 Employees.
- Vaxinano grew their employee count by 17% last year.
Vaxinano's People
| Name | Title | Email/Phone |
|---|
Vaxinano Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | N/A | 52 | 136% | N/A | N/A |
#2 | N/A | 83 | 26% | N/A | N/A |
#3 | N/A | 188 | 21% | N/A | N/A |
#4 | N/A | 141 | 152% | N/A | N/A |
#5 | N/A | 72 | 67% | N/A | N/A |
#6 | N/A | 91 | 25% | N/A | N/A |
#7 | N/A | 40 | 5% | N/A | N/A |
#8 | N/A | 41 | 141% | N/A | N/A |
#9 | N/A | 27 | 0% | N/A | N/A |
#10 | N/A | 6 | N/A | N/A | N/A |
What Is Vaxinano?
Vaxinano is a clinical-stage biotechnology company, developing a new generation of nasally administered vaccines that are more efficient and faster to deploy to combat infectious diseases and new pandemics. \n\nThe vaccine is based on STELLAR-NP nanoparticles that confer highly stable, adjuvant-free solution for an effective and long-lasting response tot protect against the most difficult pathogens, such as parasites, viruses or bacteria...
keywords:N/A
N/A
Total Funding
14
Number of Employees
N/A
Revenue (est)
17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Loos
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.2M | 14 | -7% | N/A |
#2 | $10.3M | 30 | -12% | N/A |
#3 | $10.3M | 39 | 15% | N/A |